Waters
NYSE:WAT Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
WA
Consensus Narrative from 19 Analysts
Revitalized Portfolio And High-Growth Segments Will Drive Future Success In Analytical Instruments
Key Takeaways Waters is revitalizing its product portfolio, driving revenue growth through innovation and tapping into high-growth markets like GLP-1, PFAS testing, and generics in India. Improved financial positioning allows Waters to consider strategic M&A or share repurchases, enhancing earnings per share and shareholder value.
View narrativeUS$400.84
FV
9.1% undervalued intrinsic discount5.56%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
4 days ago author updated this narrative